{"title":"Terapias biológicas contra el Virus Sincicial Respiratorio. Aprobación del uso de Nirsevimab y lo actualmente disponible en México","authors":"Felipe Aguilar Ituarte","doi":"10.18233/apm.v44i5.2801","DOIUrl":null,"url":null,"abstract":"<jats:p>no</jats:p>","PeriodicalId":6954,"journal":{"name":"Acta Pediátrica de México","volume":"304 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pediátrica de México","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18233/apm.v44i5.2801","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}